glp 1 research How RWD is transforming GLP-1 Frontiers | GLP-1R in diabetes

doi: 10.3389/fendo.2018.00649 Received 19 June 2018 Accepted 15 October 2018 Published 06 November 2018 Volume 9 - 2018 Edited by Marco Falasca, Curtin University, Australia Reviewed by Marta Letizia Hribal, Universit degli studi Magna Grcia di Catanzaro, Italy

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) such as semaglutide are no different, and Ill cover that a bit later

Of course, the injectable GLP-1 drugs are just mimicking the natural GLP hormone that your own body manufactures

This efficacy suggests the drug could be suitable for patients with greater weight loss needs, including as an alternative to more invasive treatments like bariatric surgery

Also, insurance coverage for these medications varies